Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

University of Khartoum

Status and phase: Completed; Phase 4

Conditions: Caesarean

Treatments: Drug: ceftizoxime

Study type: Interventional

Funder types: Other

Identifiers

NCT01347593

ceftizoxime cesarean

Details and patient eligibility

About

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

Enrollment: 220 patients

Sex: Female

Ages: 14 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Elective Cesarean section

Exclusion criteria

• Diabetes severe anaemia allergy

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

220 participants in 1 patient group

ceftizoxime (cefizox) injection

Experimental group

Description:

ceftizoxime (cefizox) as single dose of 1 g at the interval of 30-60 minutes before the incision

Treatment:

Drug: ceftizoxime